These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10853664)

  • 1. Inhibition of neuraminidase with neuraminic acid C-glycosides.
    Wang Q; Wolff M; Polat T; Du Y; Linhardt RJ
    Bioorg Med Chem Lett; 2000 May; 10(9):941-4. PubMed ID: 10853664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoenzymatic synthesis of neuraminic acid containing C-glycoside polymers.
    Wang Q; Dordick JS; Linhardt RJ
    Org Lett; 2003 Apr; 5(8):1187-9. PubMed ID: 12688715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
    Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
    Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation as sialidase inhibitors of xylo-configured cyclohexenephosphonates carrying glycerol side-chain mimics.
    Streicher H
    Bioorg Med Chem Lett; 2004 Jan; 14(2):361-4. PubMed ID: 14698159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorogenic sialic acid glycosides for quantification of sialidase activity upon unnatural substrates.
    Zamora CY; d'Alarcao M; Kumar K
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3406-10. PubMed ID: 23639536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus.
    Murakami M; Ikeda K; Achiwa K
    Carbohydr Res; 1996 Jan; 280(1):101-10. PubMed ID: 8581891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-Neu5Ac: a novel substrate for chromogenic assay of neuraminidase activity in bacterial expression systems.
    Fujii I; Iwabuchi Y; Teshima T; Shiba T; Kikuchi M
    Bioorg Med Chem; 1993 Aug; 1(2):147-9. PubMed ID: 8081844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.
    Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G
    Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenylated pterocarpans as bacterial neuraminidase inhibitors.
    Nguyen PH; Nguyen TN; Kang KW; Ndinteh DT; Mbafor JT; Kim YR; Oh WK
    Bioorg Med Chem; 2010 May; 18(9):3335-44. PubMed ID: 20363636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialidases From
    Wang YH
    Front Cell Infect Microbiol; 2019; 9():462. PubMed ID: 31998664
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of a sialidase (neuraminidase) isolated from Clostridium chauvoei (Jakari strain).
    Useh NM; Ajanusi JO; Esievo KA; Nok AJ
    Cell Biochem Funct; 2006; 24(4):347-52. PubMed ID: 15942928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibition of bacterial neuraminidase activity by pterocarpans isolated from the roots of Lespedeza bicolor.
    Woo HS; Kim DW; Curtis-Long MJ; Lee BW; Lee JH; Kim JY; Kang JE; Park KH
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6100-3. PubMed ID: 21911291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase-transfer-catalyzed synthesis of a phenylseleno alpha-ketoside of N-acetylneuraminic acid, (phenyl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2- selenononulopyranosid)onic acid; a new sialidase inhibitor.
    Rothermel J; Faillard H
    Carbohydr Res; 1990 Dec; 208():251-4. PubMed ID: 2085812
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological properties of N-acyl and N-haloacetyl neuraminic acids: processing by enzymes of sialic acid metabolism, and interaction with influenza virus.
    Humphrey AJ; Fremann C; Critchley P; Malykh Y; Schauer R; Bugg TD
    Bioorg Med Chem; 2002 Oct; 10(10):3175-85. PubMed ID: 12150863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building a successful structural motif into sialylmimetics-cyclohexenephosphonate monoesters as pseudo-sialosides with promising inhibitory properties.
    Streicher H; Busse H
    Bioorg Med Chem; 2006 Feb; 14(4):1047-57. PubMed ID: 16230015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of sialidase in complex with geranylated flavonoids as potent natural inhibitors.
    Lee Y; Ryu YB; Youn HS; Cho JK; Kim YM; Park JY; Lee WS; Park KH; Eom SH
    Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1357-65. PubMed ID: 24816104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tryptophan modification on the activity of bacterial and viral neuraminidase.
    Bachmayer H
    FEBS Lett; 1972 Jun; 23(2):217-9. PubMed ID: 4343930
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of synthetic inhibitors of neuraminidase and hemagglutinin for studying the functional role of active subunits of membranes of myxo- and paramyxoviruses].
    Zakstel'skaia LIa; Molibog EV; Iakhno MA; Evstigneeva NA; Isachenko VA
    Vopr Virusol; 1972; 17(2):223-8. PubMed ID: 4337525
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action specificity of neuraminidase. The action of bacterial neuraminidase on isomeric N,O-diacetylneuraminic acid glycosides in the submaxilllary mucin of horse and cow].
    Schauer R; Faillard H
    Hoppe Seylers Z Physiol Chem; 1968 Aug; 349(8):961-8. PubMed ID: 4300548
    [No Abstract]   [Full Text] [Related]  

  • 20. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
    Kai H; Hinou H; Nishimura S
    Bioorg Med Chem; 2012 Apr; 20(8):2739-46. PubMed ID: 22410247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.